News
-
31 October 2008 /Authorisation and supervision
Control of streptokinase-containing medicinal products
The Danish Medicines Agency's laboratory has tested five different products that contain the active substance streptokinase, which is used for the treatment of blood clots.
-
31 October 2008 /Authorisation and supervision
Control of oral suspensions
The Danish Medicines Agency's laboratory has analysed six different oral suspensions. The control was carried out in response to a complaint about microbiological contamination in one of the products after opening.
